Furosemide 4 mg/ml oral solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

furosemide 4 mg/ml oral solution

syri pharma limited t/a thame laboratories - furosemide - oral solution - 4 milligram(s)/millilitre - sulfonamides, plain; furosemide

Furosemide 8 mg/ml oral solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

furosemide 8 mg/ml oral solution

syri pharma limited t/a thame laboratories - furosemide - oral solution - 8 milligram(s)/millilitre - sulfonamides, plain; furosemide

Risperidone 1mg/ml Oral Solution Malta - angleščina - Medicines Authority

risperidone 1mg/ml oral solution

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - risperidone - oral solution - risperidone 1 mg/ml - psycholeptics

Risperidone 1mg/ml Oral Solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

risperidone 1mg/ml oral solution

pinewood laboratories ltd, - risperidone - oral solution - 1 milligram(s)/millilitre - other antipsychotics; risperidone

LEVENTA 1 mg/ml ORAL SOLUTION FOR DOGS Južnoafriška republika - angleščina - South African Health Products Regulatory Authority (SAHPRA)

leventa 1 mg/ml oral solution for dogs

intervet south africa (pty) ltd - solution - see ingredients - each 1,0 ml solution contains levothyroxine sodium 1,0 mg

Risperidone 1mg/ml Oral Solution Velika Britanija - angleščina - myHealthbox

risperidone 1mg/ml oral solution

rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.

Amisulpride 100mg/ml oral solution sugar free Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

amisulpride 100mg/ml oral solution sugar free

advanz pharma - amisulpride - oral solution - 100mg/1ml

RISPERDAL risperidone 1mg/mL oral liquid bottle Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

risperdal risperidone 1mg/ml oral liquid bottle

janssen-cilag pty ltd - risperidone, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: purified water; benzoic acid; tartaric acid; sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and related psychoses. risperdal is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. risperdal is also indicated for the treatment of behavioural disturbances in dementia. risperdal is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). risperdal is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

RIXADONE risperidone 1 mg/mL oral liquid solution bottle Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

rixadone risperidone 1 mg/ml oral liquid solution bottle

boucher & muir pty ltd - risperidone, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: tartaric acid; benzoic acid; purified water; hydrochloric acid - rixadone is indicated for the treatment of schizophrenia and related psychoses.,rixadone is indicated for the short-term treatment of acute mania associated with bipolar 1 disorder.,rixadone is indicated for the treatment (up to 12 weeks) of psychotic symptoms, or persistent agitation or aggression unresponsive to non-pharmacological approaches in patients with moderate to severe dementia of the alzheimer type.,rixadone is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.,rixadone is indicated for the treatment of behavioural disorders associated with autism in children and adolescents.

Dexamethasone Alapis 0.4mg/ml Oral Solution Malta - angleščina - Medicines Authority

dexamethasone alapis 0.4mg/ml oral solution

alapis s.a. - dexamethasone 0.4 mg/ml - oral solution